Sign in
4

Changes in Ownership

Taysha Gene Therapies, Inc. Filed Acc 0001209191-23-039733

Options or other derivatives

  • Director acquired 36,200 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Sepp-Lorenzino Laura Director 2023-06-22 Grant or award · Stock Option (right to buy) +36,200 36,200 D
Loading xslF345X04/doc4.xml…